Kara Dixon Capriotti MD
Dermatologic Surgery
President and Director of Dermatology, Veloce BioPharma Vice President Operations, Halodine
Join to View Full Profile
919 Conestoga RdBuilding Two, Suite 106Bryn Mawr, PA 19010
Phone+1 610-525-5028
Dr. Capriotti is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Dermatology, 2006 - 2009
Albert Einstein Medical CenterInternship, Transitional Year, 2005 - 2006
Drexel University College of MedicineClass of 2005
Certifications & Licensure
PA State Medical License 2005 - 2026
American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- Fellow (FAAD) American Academy of Dermatology
- Fellow (FASDS) American Society for Dermatologic Surgery
Clinical Trials
- ALC-919 For The Treatment Of Common Warts Start of enrollment: 2015 Apr 01
- A Study of VBP-245 in Pediatric Patients With Molluscum Contagiosum Start of enrollment: 2017 Feb 27
- A Trial to Evaluate the Efficacy and Safety of Two Concentrations of VBP-926 Solution for the Treatment of Chemotherapy-associated Paronychia in Cancer Patients Start of enrollment: 2017 Oct 24
- Join now to see all
Publications & Presentations
PubMed
- 10 citationsA randomized phase 2 trial of the efficacy and safety of a novel topical povidone-iodine formulation for Cancer therapy-associated Paronychia.Kara Capriotti, Milan J. Anadkat, Jennifer N. Choi, Benjamin Kaffenberger, Beth N. McLellan
Investigational New Drugs. 2019-06-26 - 2 citationsTopical application of povidone-iodine/dimethylsulfoxide ophthalmic gel preparation in Dutch-Belted rabbits.Jesse Pelletier, John Devine, Kara Capriotti, Samuel B. Barone, Capriotti Joseph A
Cutaneous and Ocular Toxicology. 2019-03-22 - 11 citationsChemotherapy-associated paronychia treated with 2% povidone-iodine: a series of cases.Kara Capriotti, Capriotti Joseph A, Jesse Pelletier, Kevin Stewart
Cancer Management and Research. 2017-06-26
Press Mentions
Veloce BioPharma Announces Positive Phase 2b Study Results for VBP-926 for Chemotherapy-Associated ParonychiaOctober 3rd, 2018
New Gel Effective in Treating Molluscum ContagiosumMarch 5th, 2017
Professional Memberships
- Fellow
- Fellow
External Links
- Veloce BioPharmahttp://velocebiopharma.com
- Halodinehttp://halodine.com
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
